Clinical trial
Specificity and Sensitivity of Glycosaminoglycan Scores in the Early Diagnosis of Recurrent Renal Cell Carcinoma
NCT02732652 is registered in ClinicalTrials.gov with Chalmers University of Technology as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Specificity and Sensitivity of Glycosaminoglycan Scores in the Early Diagnosis of Recurrent Renal Cell Carcinoma
- Lead sponsor
- Chalmers University of Technology
- Phase
- Observational
- Overall status
- Completed
- Start date
- June 30, 2016
- Completion date
- September 30, 2021
- Enrollment
- 72 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.